(FOXFIRE Global STX0112) Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-Line Treatment in Patients with Non-Resectable Liver Metastases from Primary Colorectal Carcinoma in a Randomized Clinical Study
Description: 

To compare the efficacy and safety of selective internal radiation therapy (SIRT) using SIR-Spheres microspheres plus a standard chemotherapy regimen of FOLFOX6m versus FOLFOX6m alone as first-line therapy in patients with non-resectable liver metastases from primary colorectal carcinoma.

Study Number: 

PH 235813

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01721954

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.